Bill

Bill > SB382


OR SB382

OR SB382
Relating to exemption of prescription drug sales; prescribing an effective date.


summary

Introduced
01/13/2025
In Committee
01/17/2025
Crossed Over
Passed
Dead
06/27/2025

Introduced Session

2025 Legislative Measures

Bill Summary

The statement includes a measure digest written in compliance with applicable readability standards. Digest: The Act makes all pharmacy drug sale receipts not taxed by the corporate activity tax. (Flesch Readability Score: 61.8). Exempts receipts from the sale of prescription drugs by all licensed retail pharmacies from commercial activity subject to the corporate activity tax. Applies to tax years beginning on or after January 1, 2026. Takes effect on the 91st day following adjournment sine die.

AI Summary

This bill amends Oregon Revised Statutes (ORS) to provide a tax exemption for prescription drug sales by removing the previous limitation that only pharmacies with nine or fewer locations could qualify. The bill eliminates the previous restriction on "eligible pharmacies" and now extends the corporate activity tax exemption to all pharmacies selling prescription drugs, regardless of the number of locations they operate. Under this legislation, receipts from prescription drug sales will be completely excluded from the definition of commercial activity and exempted from the tax imposed under ORS 317A.116. The tax exemption will apply to tax years beginning on or after January 1, 2026, and the bill itself will take effect on the 91st day following the adjournment of the 2025 regular session of the Oregon Legislative Assembly. The term "pharmacy" is defined according to ORS 689.005, and the change aims to provide a broader tax relief for pharmacies selling prescription drugs in the state.

Committee Categories

Budget and Finance

Sponsors (4)

Last Action

In committee upon adjournment. (on 06/27/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...